2020-New-Mach7-Logo_Tagline-PNG_Transparent-2000x700px.png
Client Outlook Announces Partnership with InTouch Health to Deliver Next Generation Telehealth Image Viewing Solution
February 28, 2018 10:00 ET | Client Outlook
WATERLOO, Ontario, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Client Outlook, leading developer of healthcare imaging solutions, announced today the planned integration of its eUnity diagnostic and clinical...
Tech-Assist-PR Image 020618
ALLDATA ramps up its Master Technician diagnostic hotline – Now offers Tech-Assist 7 days a week plus live video-streaming
February 26, 2018 14:48 ET | ALLDATA, LLC
ELK GROVE, Calif., Feb. 26, 2018 (GLOBE NEWSWIRE) -- ALLDATA, an AutoZone company, recently expanded its diagnostic and repair hotline service, ALLDATA Tech-Assist®. The company hired additional...
2020-New-Mach7-Logo_Tagline-PNG_Transparent-2000x700px.png
Client Outlook Announces Partnership with Purview to Deliver Integrated Image Access and Viewing Solutions for Physicians and Patients
November 07, 2017 07:00 ET | Client Outlook
WATERLOO, Ontario, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Client Outlook Inc., the developer of FDA Class II diagnostic and clinical imaging software platform, eUnity, announced today a new partnership...
2020-New-Mach7-Logo_Tagline-PNG_Transparent-2000x700px.png
Client Outlook’s eUnity™ Selected as the Enterprise Image Viewing Platform for Tampa General Hospital
September 07, 2017 07:00 ET | Client Outlook
WATERLOO, Ontario, Sept. 07, 2017 (GLOBE NEWSWIRE) -- Client Outlook, a leading provider of FDA Class II diagnostic and clinical image viewing solutions, announced today that Tampa General Hospital...
Recent Publication H
Recent Publication Highlights Proof-of-Concept Data Supporting the Diagnostic Potential of Phosphatidylserine-Positive Exosomes in Ovarian Cancer
February 09, 2017 08:05 ET | Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., Feb. 09, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a biopharmaceutical company committed to improving patient lives by manufacturing high...
AAA_Logo_Final_RGB.jpg
Advanced Accelerator Applications Announces European Commission Approval of SomaKit TOC™
December 15, 2016 07:00 ET | Advanced Accelerator Applications
SAINT-GENIS-POUILLY, France, Dec. 15, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or “the Company”), an international specialist in molecular nuclear...
Elsevier and the International Society for Neurovascular Disease Partner on Co-branded Neurovascular Disease Book Series
September 29, 2016 04:00 ET | Elsevier, Inc.
CAMBRIDGE, MA--(Marketwired - September 29, 2016) - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that it has partnered...
AAA_Logo_Final_RGB.jpg
Advanced Accelerator Applications Announces Positive EMA Opinion on Application for SomaKit TOC Kit for Radiopharmaceutical Preparation of Gallium (Ga 68) Edotreotide for Gastroenteropancreatic Neuroendocrine Tumor Detection
September 16, 2016 07:00 ET | Advanced Accelerator Applications
SAINT-GENIS-POUILLY, France, Sept. 16, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or “the Company”), an international specialist in molecular nuclear...
AAA_Logo_Final_RGB.jpg
Advanced Accelerator Applications Announces Two Phase II Studies Evaluating 99MrhAnnexin V-128 Imaging in Cardiovascular and Cardio-Oncology Indications at University of Ottawa Heart Institute and Ottawa Hospital
September 06, 2016 07:00 ET | Advanced Accelerator Applications
SAINT-GENIS-POUILLY, France, Sept. 06, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or the “Company”), an international specialist in Molecular Nuclear...
AAA_Logo_Final_RGB.jpg
Advanced Accelerator Applications Announces FDA Approval of NETSPOT™ (Somakit-TATE), a Kit for the Preparation of Gallium Ga 68 Dotatate for Neuroendocrine Tumor Detection
June 02, 2016 07:00 ET | Advanced Accelerator Applications
SAINT-GENIS-POUILLY, France, June 02, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or “the Company”), an international specialist in molecular nuclear...